UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments

Journal of Oncology, 2015-01, Vol.2015 (2015), p.358-368

2015

Volltextzugriff (PDF)

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

Frontiers in oncology, 2019-03, Vol.9, p.129-129

2019

Volltextzugriff (PDF)

Socioeconomic status and lifestyle patterns in the most common cancer types-community-based research

BMC public health, 2023-09, Vol.23 (1), p.1-1722, Article 1722

2023

Volltextzugriff (PDF)

Area-based disparities in non-small-cell lung cancer survival

Acta oncologica, 2024-04, Vol.63 (1), p.146-153

2024

Volltextzugriff (PDF)

Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review

Frontiers in oncology, 2021-10, Vol.11, p.754427-754427

2021

Volltextzugriff (PDF)

Role of patient characteristics in adherence to first-line treatment guidelines in breast, lung and prostate cancer: insights from the Nordic healthcare system

BMJ open, 2024-04, Vol.14 (4), p.e084689-e084689

2024

Volltextzugriff (PDF)

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT

Radiation oncology (London, England), 2022-01, Vol.17 (1), p.19-9, Article 19

2022

Volltextzugriff (PDF)

Clinicians’ Expectations for Gene-Driven Cancer Therapy

Clinical Medicine Insights. Oncology, 2014-01, Vol.2014 (8), p.159-164

Jekunen, Antti

2014

Volltextzugriff (PDF)

Current challenges in applying gene-driven therapies in clinical lung cancer practice

World journal of clinical oncology, 2021-08, Vol.12 (8), p.656-663

2021

Volltextzugriff (PDF)

Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population

Cancer chemotherapy and pharmacology, 2021-05, Vol.87 (5), p.657-663

2021

Volltextzugriff (PDF)

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

The Lancet regional health. Europe, 2021-04, Vol.3, p.100049-100049, Article 100049

2021

Volltextzugriff (PDF)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

BMC cancer, 2017-09, Vol.17 (1), p.620-620, Article 620

2017

Volltextzugriff (PDF)

Role of radiopharmaceuticals in development of inhaled drugs

Current pharmaceutical design, 2009-03, Vol.15 (9), p.943-949

Jekunen, Antti P

2009

Volltextzugriff (PDF)

Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment

Case reports in oncology, 2021-10, Vol.14 (3), p.1475-1482

2021

Volltextzugriff (PDF)

Impact of sex and age on adherence to guidelines in non-small cell lung cancer management

Cancer treatment and research communications, 2023, Vol.34, p.100675-100675, Article 100675

2023

Volltextzugriff (PDF)

Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment

Oncology, 2019-03, Vol.96 (3), p.115-124

2019

Volltextzugriff (PDF)

Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2022-09, Vol.171, p.9-17

2022

Volltextzugriff (PDF)

Decision-making in product portfolios of pharmaceutical research and development--managing streams of innovation in highly regulated markets

Drug design, development and therapy, 2014-01, Vol.8 (default), p.2009-2016

Jekunen, Antti

2014

Volltextzugriff (PDF)

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

The New England journal of medicine, 2017-06, Vol.376 (25), p.2415-2426

2017

Volltextzugriff (PDF)

Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review

Acta oncologica, 2020-07, Vol.59 (7), p.775-785

2020

Volltextzugriff (PDF)

A Phase I Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously Daily for 5 Consecutive Days Every 3 Weeks in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-11, Vol.11 (21), p.7807-7816

2005

Volltextzugriff (PDF)

Clinicians' Expectations for Gene-Driven Cancer Therapy

Clinical Medicine Insights. Oncology, 2014-12, Vol.2014 (8), p.159-164

Antti Jekunen

2014

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously on Days 1, 3, and 5 Every 3 Weeks in Patients with Advanced Solid Tumors

Clinical cancer research, 2005-11, Vol.11 (21), p.7825-7833

2005

Volltextzugriff (PDF)

Real-World, Retrospective Data of Pancreatic Cancer Treatment Outcomes

Pancreas, 2022-02, Vol.51 (2), p.e18-e20

2022

Volltextzugriff (PDF)

Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison

Acta oncologica, 2017-07, Vol.56 (7), p.943-948

2017

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of Rebiopsy in Relapsed Non-Small Cell Lung Cancer for Directing Oncology Treatments

The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer

Socioeconomic status and lifestyle patterns in the most common cancer types-community-based research

Area-based disparities in non-small-cell lung cancer survival

Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review

Role of patient characteristics in adherence to first-line treatment guidelines in breast, lung and prostate cancer: insights from the Nordic healthcare system

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT

Clinicians’ Expectations for Gene-Driven Cancer Therapy

Current challenges in applying gene-driven therapies in clinical lung cancer practice

Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population

Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population

Role of radiopharmaceuticals in development of inhaled drugs

Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment

Impact of sex and age on adherence to guidelines in non-small cell lung cancer management

Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment

Effect of adherence to treatment guidelines on overall survival in elderly non-small-cell lung cancer patients

Decision-making in product portfolios of pharmaceutical research and development--managing streams of innovation in highly regulated markets

First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer

Recent clinical evidence on metronomic dosing in controlled clinical trials: a systematic literature review

A Phase I Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously Daily for 5 Consecutive Days Every 3 Weeks in Patients with Advanced Solid Tumors

Clinicians' Expectations for Gene-Driven Cancer Therapy

Phase I and Pharmacokinetic Study of the Dolastatin-15 Analogue Tasidotin (ILX651) Administered Intravenously on Days 1, 3, and 5 Every 3 Weeks in Patients with Advanced Solid Tumors

Real-World, Retrospective Data of Pancreatic Cancer Treatment Outcomes

Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison

Suchergebnisse filtern